Glycopyrronium 12.5mcg + Formeterol fumarate dihydrate 12mcg + Fluticasone propionate 250mcg powder for inhalation

All marketing authorization holders of medicine are hereby informed that black warning as "NOT TO USE IN ASTHMA" should be included in labels of Glycopyrronium 12.5mcg + Formeterol fumarate dihydrate 12mcg + Fluticasone propinate 250mcg powder for inhalation in three language and to consider it as schedule IIC medicine.

(Date: 07 September 2022)